Overview

Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial

Status:
Terminated

Trial end date:
2020-11-30

Target enrollment:

Participant gender:

Summary

This is an open label clinical study to evaluate the activity of chloroquine phosphate in patients with SARS-CoV-2 virus infection. The study aims to document possible prevention of pneumonia in patients staying at home and in improving the symptoms of SARS-CoV-2 pneumonia in patients who will be hospitalised.

Phase:

Phase 2

Details

Lead Sponsor:

Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.

Collaborators:

AHEPA University Hospital
Athens General Hospital Hippokrateio
Athens General Hospital of Thoracic Diseases SOTIRIA
Corfu General Hospital Agia Irini
Divine Providence Hospital Pammakaristos
General Hospital of Athens Sismanoglio
University General Hospital of Ioannina

Treatments:

Chloroquine
Chloroquine diphosphate